1
|
Li J, Jiang S, Huang C, Lu B, Yang X. Identification and validation of genes associated with aging-related cardiovascular disease. FASEB J 2024; 38:e23370. [PMID: 38168496 DOI: 10.1096/fj.202301270rr] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2023] [Revised: 11/15/2023] [Accepted: 11/30/2023] [Indexed: 01/05/2024]
Abstract
Aging is acknowledged as the most significant risk factor for cardiovascular disease (CVD). This study sought to identify and validate potential aging-related genes associated with CVD by using bioinformatics. The confluence of the limma test, weighted correlation network analysis (WGCNA), and 2129 aging and senescence-associated genes led to the identification of aging-related differential expression genes (ARDEGs). By using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG), potential biological roles and pathways of ARDEGs were identified. To find the significantly different functions between CVD and non-cardiovascular disease (nCVD) and to reckon the processes score, enrichment analysis of all genes was carried out using gene set enrichment analysis (GSEA) and gene set variation analysis (GSVA). By using GO and KEGG, potential biological roles and pathways of ARDEGs were identified. To evaluate the immune cell composition of the immune microenvironment, we performed an immune infiltration analysis on the dataset from the training group. We were able to acquire four ARDEGs (PTGS2, MMP9, HBEGF, and FN1). Aging, cellular senescence, and nitric oxide signal transduction were selected for biological function analysis. The diagnostic value of the four ARDEGs in distinguishing CVD from nCVD samples was deemed to be favorable. This research identified four ARDEGs that are associated with CVD. This study provides insight into prospective novel biomarkers for aging-related CVD diagnosis and progression monitoring.
Collapse
Affiliation(s)
- Jing Li
- School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, P. R. China
| | - Shengping Jiang
- School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, P. R. China
| | - Chengyun Huang
- School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, P. R. China
| | - Baihui Lu
- School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, P. R. China
| | - Xiaolong Yang
- School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, P. R. China
| |
Collapse
|
2
|
Zhang J, Chen C, Li F, Gao G, Fu J, Niu H, Yu K, Wang L, Guo R, Wan Y, Ma Z, Zhang Q, Mu L, Liu J, Yang J, Wang L. Different Changing Patterns of Three NOS-NO System Activities after Ischemia-Reperfusion in Rabbit with AMI. Cell Biochem Biophys 2021; 79:857-862. [PMID: 34125429 DOI: 10.1007/s12013-021-01011-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2020] [Accepted: 06/02/2021] [Indexed: 10/21/2022]
Abstract
NOS-NO system activity is closely correlated with ischemia-reperfusion injury (IRI) and NOS subtypes were suggested to play different roles in IRI. In this work, the activity of serum NOS, NO levels, and ischemic necrosis after reperfusion in rabbit with AMI at different time was studied. We also explored the NOS-NO system activity changes and its correlation with myocardial ischemia and necrosis. It shows that after reperfusion in rabbits with AMI, NO-NOS system activities present different changes at each time point due to inactivation of NO and iNOS activation, and different experimental animals, ischemia-reperfusion degree, and length of time will also lead to different research results. Therefore, it is necessary to conduct dynamic observation on animals from different species at multi-temporal point under the state of NOS-NO system activities, and simultaneously detect inflammatory factor, MDA, and SOD indexes. Therefore, it is a must to conduct relevant drug research studies to make NOS-NO system activities maintain the level in favor of ideal myocardial ischemia reperfusion.
Collapse
Affiliation(s)
- Jun Zhang
- Department of Cardiology, CangZhou Central Hospital, CangZhou, Hebei, China.
| | - Chao Chen
- Department of Cardiology, CangZhou Central Hospital, CangZhou, Hebei, China
| | - Fengpeng Li
- Department of Cardiology, CangZhou Central Hospital, CangZhou, Hebei, China
| | - Guangren Gao
- Department of Cardiology, CangZhou Central Hospital, CangZhou, Hebei, China
| | - Jinguo Fu
- Department of Cardiology, CangZhou Central Hospital, CangZhou, Hebei, China
| | - Heping Niu
- Department of Cardiology, CangZhou Central Hospital, CangZhou, Hebei, China
| | - Kai Yu
- Department of Cardiology, CangZhou Central Hospital, CangZhou, Hebei, China
| | - Lei Wang
- Department of Cardiology, CangZhou Central Hospital, CangZhou, Hebei, China
| | - Run Guo
- Department of Cardiology, CangZhou Central Hospital, CangZhou, Hebei, China
| | - Yanfang Wan
- Department of Cardiology, CangZhou Central Hospital, CangZhou, Hebei, China
| | - Zhanfeng Ma
- Department of Cardiology, CangZhou Central Hospital, CangZhou, Hebei, China
| | - Qianyu Zhang
- Department of Cardiology, CangZhou Central Hospital, CangZhou, Hebei, China
| | - Liping Mu
- Department of Cardiology, CangZhou Central Hospital, CangZhou, Hebei, China
| | - Jing Liu
- Department of Cardiology, CangZhou Central Hospital, CangZhou, Hebei, China
| | - Jing Yang
- Department of Cardiology, CangZhou Central Hospital, CangZhou, Hebei, China
| | - Linlin Wang
- Department of Cardiology, CangZhou Central Hospital, CangZhou, Hebei, China
| |
Collapse
|
3
|
Liu M, Sun Q, Wang Q, Wang X, Lin P, Yang M, Yan Y. Effect of trapidil in myocardial ischemia-reperfusion injury in rabbit. Indian J Pharmacol 2014; 46:207-10. [PMID: 24741195 PMCID: PMC3987192 DOI: 10.4103/0253-7613.129320] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/20/2013] [Revised: 08/08/2013] [Accepted: 02/10/2014] [Indexed: 12/29/2022] Open
Abstract
OBJECTIVES To evaluate the cardioprotective effects of trapidil on myocardial ischemia-reperfusion injury (MIRI) in rabbits. MATERIALS AND METHODS Rabbits were subjected to 40 min of myocardial ischemia followed by 120 min of reperfusion. Blood for superoxide dismutase (SOD) and malondialdehyde (MDA) were estimated. At the end of reperfusion, the rabbits were sacrificed and the hearts were isolated for histological examination. An apoptotic index (AI) was determined using the terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end-labeling (TUNEL) method. The expression of apoptosis-related proteins Bax and Bcl-2 was analyzed using immunohistochemistry. Statistical analyses were performed by one-way analysis of variance (ANOVA), P < 0.05 considered statistically significant. RESULTS Trapidil caused a significant (P < 0.05) increase in SOD activity, as decreased MDA levels and significantly (P < 0.05) reduced the expression of Bax as compared with the ischemia-reperfusion (IR) control group. CONCLUSION Trapidil may attenuate the myocardial damage produced by IR injury and offer potential cardioprotective action.
Collapse
Affiliation(s)
- Mingjie Liu
- The First Hospital of Jilin University, Changchun, Jilin 130000, China ; Inner Mongolia University for the Nationalities, Tongliao, Inner Mongolia 028000, China
| | - Qi Sun
- The First Hospital of Jilin University, Changchun, Jilin 130000, China ; 202 Military Hospital of China, Shenyang, Liaoning 110000, China
| | - Qiang Wang
- 202 Military Hospital of China, Shenyang, Liaoning 110000, China
| | - Xiuying Wang
- Liaoning Provincial Institute of Food and Drug Control, Shenyang, Liaoning 110000, China
| | - Peng Lin
- Liaoning Provincial Institute of Food and Drug Control, Shenyang, Liaoning 110000, China
| | - Ming Yang
- Liaoning Provincial Institute of Food and Drug Control, Shenyang, Liaoning 110000, China
| | - Yuanyuan Yan
- Liaoning Provincial Institute of Food and Drug Control, Shenyang, Liaoning 110000, China
| |
Collapse
|